The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

synapdx.com

Stage

Series C | Dead

Total Raised

$32.4M

Last Raised

$15.4M

About SynapDx

SynapDx is an early stage laboratory services company developing a blood based test to enable earlier detection of Autism Spectrum Disorders (ASDs). ASDs are characterized by impairment in language and socialization as well as restricted and repetitive behaviors. ASDs affect 1 in 88 children according to the Centers for Disease Control. SynapDx's approach measures RNA gene expression differences, which current research suggests can distinguish between people with ASDs and those without. SynapDx is in the process of conducting additional studies to validate this approach.

SynapDx Headquarter Location

Four Hartwell Place

Lexington, Massachusetts, 02421,

United States

508-485-5820

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

SynapDx Patents

SynapDx has filed 7 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/9/2016

1/7/2020

Amphetamine, Stimulants, Psychiatric diagnosis, Nootropics, Childhood psychiatric disorders

Grant

Application Date

2/9/2016

Grant Date

1/7/2020

Title

Related Topics

Amphetamine, Stimulants, Psychiatric diagnosis, Nootropics, Childhood psychiatric disorders

Status

Grant

Latest SynapDx News

Giant CreativeStrategy to Host Live Campfire Chats During TEDMEDs Hive

Sep 8, 2014

SynapDx Corporation to be Featured at TEDMED’s The HIVE Event Giant Creative/Strategy, LLC , the largest full-service independent healthcare communications agency on the West Coast with offices in San Francisco and Philadelphia, will host CampFire, a pop-up conversation pod, during TEDMED 2014, the annual, multi-disciplinary gathering where leaders from all sectors of society come together to explore the promise of technology and potential of human achievement in health and medicine. This year, TEDMED 2014 will take place simultaneously on two stages in Washington, D.C. and San Francisco from Sept. 10 - 12. At TEDMED 2014, two teams from Giant will catalyze conversations among small groups and through moderated discussions with registered delegates in each city at The Hive, TEDMED’s informal social environment that spotlights innovations by startups and entrepreneurs across the healthcare landscape. Giant’s goal is to convene enterprising people and their views that could lead to powerful collaborations and accelerate health progress. CampFire commentary will be posted on Twitter @GiantAgencySF using #TEDMEDHive. “CampFire will ignite provocative insights about healthcare trends and new opportunities and encourage others to imagine a healthier world,” said Christine Armstrong, Managing Director, Brand Experience. “Giant’s teams will steer conversations to crystalize into even bigger considerations that can be shared within the TEDMED community and beyond.” CampFire will be held from 7 a.m. – 7 p.m. EDT and PDT. “CampFire will bring innovators, entrepreneurs and thought leaders into one global, collaborative environment where opportunities to work together in the future may cultivate,” said Eric Steckelman, SVP, Managing Director. TEDMED is the independently owned health and medicine arm of the internationally known TED conference. About Giant Creative/Strategy, LLC Giant is the largest full-service independent healthcare communications agency on the West Coast and now has a full-service office in Philadelphia to provide greater geographic proximity to East Coast accounts. Giant specializes in positioning and branding, strategic and creative development, delivering innovative ideas across multi-channel execution for pharmaceutical, biotech, medical device, and diagnostics companies. In 2013, Giant won the Manny Awards Agency of the Year Category II. By putting the most seasoned professionals on the front lines of each piece of business, Giant consistently exceeds expectations through Giant insights, ideas, and execution. Together with its clients, Giant Creative/Strategy builds Giant brands and delivers Giant results. Giant Creative/Strategy

  • Where is SynapDx's headquarters?

    SynapDx's headquarters is located at Four Hartwell Place, Lexington.

  • What is SynapDx's latest funding round?

    SynapDx's latest funding round is Series C.

  • How much did SynapDx raise?

    SynapDx raised a total of $32.4M.

  • Who are the investors of SynapDx?

    Investors of SynapDx include General Catalyst, North Bridge Venture Partners, Bain Capital Ventures, Google Ventures, Flare Capital Partners and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.